About aTTP/iTTP CABLIVI (caplacizumab-yhdp)

Cablivi (caplacizumab) for acquired thrombotic thrombocytopenic purpura

PDF) Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

CABLIVI (caplacizumab-yhdp) Efficacy for HCPs

Diagnosing aTTP/iTTP CABLIVI (caplacizumab-yhdp) for HCPs

CABLIVI (caplacizumab-yhdp) for Adults with aTTP/iTTP

These highlights do not include all the information needed to use CABLIVI® safely and effectively. See full prescribing information for CABLIVI. CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use Initial U.S.

Caplacizumab - wikidoc

Llama-inspired antibody fragment approved for rare blood disorder

Coping with Relapse: Heather's aTTP Story

(caplacizumab) is a medicine approved for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP). It is

Cablivi